Phosphorylation of the androgen receptor is associated with reduced survival in hormone-refractory prostate cancer patients

Cell line studies demonstrate that the PI3K/Akt pathway is upregulated in hormone-refractory prostate cancer (HRPC) and can result in phosphorylation of the androgen receptor (AR). The current study therefore aims to establish if this has relevance to the development of clinical HRPC. Immunohistoche...

Descripción completa

Detalles Bibliográficos
Autores principales: McCall, P, Gemmell, L K, Mukherjee, R, Bartlett, J M S, Edwards, J
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2008
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2275485/
https://www.ncbi.nlm.nih.gov/pubmed/18349820
http://dx.doi.org/10.1038/sj.bjc.6604152

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2275485/
https://www.ncbi.nlm.nih.gov/pubmed/18349820
http://dx.doi.org/10.1038/sj.bjc.6604152

Ejemplares similares